SNNC Sibannac Inc (PK)

 

Sibannac, Inc.

 

 

Michael Davis

Division of Corporation Finance

Office of Life Sciences

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

 

	Re:	Sibannac, Inc.
		Form 1A/A Amendment Withdrawal
		Regulation A Offering Statement on Form 1-A
		File No. 024-11780

 

February 16, 2023

 

Dear Mr. Davis,

 

This letter sets forth the request of Sibannac, Inc., (“SNNC” or the “Company”) for the Withdrawal of its Form 1-A Amendment to its Regulation A Offering on Form 1-A/A.

 

Sibannac, Inc., (Applicant) pursuant to Rule 259 of Regulation A and via this 1-AW filing, hereby applies for the Commission’s consent to withdraw its Form 1-A/A Offering Statement dated February 15, 2023, file number 024-111780.

 

The Offering Statement was submitted as a Form 1-A/A instead of as a new Form 1-A. The correct Offering Statement will be resubmitted under Form 1-A. The Company also affirms that no securities were sold under the Form 1-A Amendment on Form 1-A/A filing.

 

We trust the foregoing is in order.

 

If you have any questions or require any additional information with respect to the above, please do not hesitate to contact me at (480) 407-6445 or Carl Ranno, Esq. at (602) 493-0369. Thank you for your attention to this matter.

 

 

	Sibannac, Inc.
	/s/David Mersky
	Name: David Mersky
	Title: Chief Executive Officer, Director